StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NYSE · FMS·Healthcare

Fresenius Medical Care AG & Co. KGaA Stock Analysis & AI Score

Fresenius Medical Care AG & Co. KGaA (FMS) has an ST Score of 47.8 (C+), driven by its Profitability (B) and held back by its Momentum (D). Analysts rate it Hold with a $23.57 price target (+5.5% upside).

Market Closed
$22.35
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
48
ST Score
47.8/100C+

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryMedical - Care Facilities
IPO Date—
Website—
Country—
ExchangeNYSE

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

FMS
47.8out of 100
Grade C+

Fresenius Medical Care AG & Co. KGaA (FMS) has an ST Score of 47.8 (C+), driven by its Profitability (B) and held back by its Momentum (D). Analysts rate it Hold with a $23.57 price target (+5.5% upside).

Strongest
ProfitabilityB
Weakest
MomentumD
All factor grades
  • ProfitabilityB
  • ValuationC+
  • Financial StrengthC+
  • ForecastC+
  • GrowthD+
  • MomentumD
  • Piotroski8/9
Score methodology
Press Releases

Contact

FMS stock: frequently asked questions

What is FMS's ST Score?

Fresenius Medical Care AG & Co. KGaA (FMS) has an ST Score of 47.8 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is FMS a buy, hold, or sell?

Analysts rate FMS a Hold, with a price target of $23.57 (+5.5% vs the current price). Our ST Score grades it C+ (47.8/100). The ST Score is a data-driven signal, not a recommendation.

What are FMS's factor grades?

Valuation C+, Profitability B, Financial Strength C+, Momentum D, Growth D+, Forecast C+.

What is FMS's valuation grade?

Fresenius Medical Care AG & Co. KGaA (FMS) earns a valuation grade of C+, measured against Medical - Care Facilities peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is FMS's growth grade?

Fresenius Medical Care AG & Co. KGaA (FMS) earns a growth grade of D+, measured against Medical - Care Facilities peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is FMS's profitability grade?

Fresenius Medical Care AG & Co. KGaA (FMS) earns a profitability grade of B, measured against Medical - Care Facilities peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is FMS's financial strength grade?

Fresenius Medical Care AG & Co. KGaA (FMS) earns a financial strength grade of C+, measured against Medical - Care Facilities peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is the analyst price target for FMS?

The average analyst price target for Fresenius Medical Care AG & Co. KGaA (FMS) is $23.57 from 21 analysts, which is +5.5% versus the recent price of $22.35.

What is FMS's Piotroski score?

Fresenius Medical Care AG & Co. KGaA (FMS) has a Piotroski F-Score of 8 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.